Delivery Order SPE2DB22D2206-SPE2DB25FFM01

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Bromfenac Sodium 0.09% Eye Drops 1.7 mL. The contract has a firm-fixed price and a ceiling value of $1,860.93. It was awarded on August 7, 2024, with an ultimate completion date of August 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Bromfenac Sodium 0.09% Eye Drops, 1.7ML, with a ceiling value of $3,011.19. It is a Firm Fixed Price Delivery Order contract with a period of performance ending on February 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,448.90 firm fixed-price contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription medication used to treat eye inflammation and pain. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Bromfenac Sodium 0.09% eye drops. The contract, valued at $1,138.02, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Bromfenac Sodium 0.07% Eye Drops, 3mL. The contract has a ceiling value of $1,059.39 and a completion date of August 1, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,516.82 order is for the supply of Bromfenac Sodium 0.09% Eye Drops in 1.7 ml containers, with a completion date of January 26, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription medication, with a ceiling value of $1,543.80 and a completion date of October 30, 2024. This appears to be a Firm Fixed Price delivery order contract, which is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $3,749.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Bromfenac Sodium 0.09% Eye Drops, a pharmaceutical product used for the treatment of eye conditions. The contract has an ultimate completion date of March 11, 2024, and is a Firm Fixed Price contract. This award is a child contract under a larger...
This federal contract award, valued at $1,517.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFM01
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bromfenac Sodium 0.09% eye drops. The contract has a ceiling value of $1,303.05 and a period of performance through February 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition.

The contract is a delivery order off of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 5/7/25, 9:54 AM